Cell Therapy in Idiopathic Pulmonary Fibrosis†
Idiopathic pulmonary fibrosis is a fatal disease with no effective or curative treatment options. In recent decades, cell-based therapies using stem cells or lung progenitor cells to regenerate lung tissue have experienced rapid growth in both preclinical animal models and translational clinical stu...
Main Author: | Anna Serrano-Mollar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3271/6/3/64 |
Similar Items
-
Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
by: Yun Shi, et al.
Published: (2019-06-01) -
A pre‐investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis
by: Jhon Cores, et al.
Published: (2020-07-01) -
New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis
by: Zhao Ni Wang, et al.
Published: (2020-09-01) -
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
by: Deng-Yuan Li, et al.
Published: (2021-08-01) -
Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)